Daily Products To Cutting Edge Treatments

Ann Coulter takes on Howard Dean about Wal-Mart SCOTUS decision

By a 5-4 margin, the  Supreme Court ruled yesterday that a class-action lawsuit filed in California had failed to prove gender discrimination was a widespread policy of Wal-Mart. The markets rallied after the high court dismissed the suit, and some observers heralded the decision as a positive sign for business in the United States.

On Monday’s “The Kudlow Report” on CNBC, conservative pundit and “Demonic” author Ann Coulter took on former Democratic National Committee chairman and CNBC contributor Howard Dean on the merits of the decision. Coulter explained the circumstances where a class action lawsuit would have been appropriate, such as when a broad range of individuals in similar circumstances are affected in a way that each individual case would not make financial sense to try separately.

“[H]ere you have none of that,” Coulter said. “You have, as you bring up, absolutely individual circumstances with each employee — not only that, you have individual circumstances with each manager. All of these employees have different managers determining what they get paid, how long they work, what their work treatment is like. The reason they wanted a class action in California was because of the Ninth Circuit, which is very anti-employer. It’s an insane case for a class-action case. And not surprisingly, 9-0, the court reject this had case, although at the risk of having the market collapse again, it was 5-4 with the four liberals saying that they could have brought a class-action under a different theory.”

Dean was less impressed with the Court’s decision and declared it an “anti-worker court,” but noted that the decision didn’t absolve Wal-Mart of the discrimination charges.

“Look, first of all, it’s important to note that the court did not find there was no discrimination,” Dean said. “That I didn’t hear anybody trying to claim that they found there was no discrimination. There could be. We don’t know that. That’s an issue that has to be tried. I hope a public interest lawyer who doesn’t rely on the 30 percent or whatever it is commission will be able to still try the case and find out. Secondly, it is true. This is a tough decision for employees. This is a pro-business court which makes it an anti-worker court, I guess in this context. I personally don’t think that’s a good thing for the country. I think right now, the corporate balance sheets have recovered fully from the crash of September 2008. But the balance sheets of the American families haven’t recovered. I think we’re out of balance. You know, I’m not a lawyer. I can’t say whether the — if they had a unanimous decision saying this particular one wasn’t the right way to certify it, we have to respect the unanimous decisions of the Supreme Court.

(PWRM, SRE, WMT, NHPR, FDO) Stock in Review by DrStockPick.com ...

Power3 Medical Products, Inc (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Power3 Medical Products, Inc. strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. The Company will be guided in all of its dealings with its customers, partners, shareholders, associates and investors by the philosophy of best practices.

Alzheimer’s disease is the commonly occurring form of dementia. In this disorder the patient loses social and intellectual abilities when it becomes severe the result is found to interfere with activities of daily living. In this degeneration of the healthy brain tissue takes place which results in decline of memory and mental abilities. Those suffering from alzheimer’s disease need support, care and affection from family and friends to cope up with this disease.

Nowadays, the modern researches to have a clear picture of causes of Alzheimer more than years ago. Alzheimer’s disease sufferers have large tangles and plaques in their brain. The brain nerve cell spaces accumulate by beta amyloids’ proteins which the plaques are deposits of it. Twisting and congregate inside the brain nerve cells are caused by protein tau which are tangles are deposits it.

Cutting-Edge Therapies for Autism 2010-2011

Beat Sugar Addiction Now!, The Cutting-Edge Program That Cures Your Type of Sugar Addiction and Puts You on the Road to Feeling Great - and Losing Weight!

A Baby at Last!, The Couple's Complete Guide to Getting Pregnant--from Cutting-Edge Treatments to Commonsense Wisdom

Palm Beach Life

Vegetarian Times